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1. Introduction 
Recent studies have revealed the existence of 
endoglycosidases pecific for heparan-sulfate [1,2]. 
Heparan sulfate is split by these enzymes into 
oligosaccharides. The number of linkages susceptible 
to these endoglycosidases eems to be limited. 
Previous studies on the structure of hepar&sulfate 
chains isolated from fibroblasts of patients with 
heparan-sulfate-storing enetic mucopolysacchari- 
doses gave insight into the linkage type split by 
these endoglycosidases [3]. Heparan-sulfate chains 
that accumulate due to the deficiency of an 
exoglycosidase represent oligosaccharides with 
glucosamine and uranic acid residues as reducing 
terminals, thus suggesting the participation of 
endohexosaminidase(s) and endohexuronidase(s) 
in the degradation of heparan-sulfate. The present 
study extends these findings to the reducing 
terminals of heparan-sulfates that accumulate due 
to the deficiency of specific sulfatases. The demon- 
stration of D-glucuronic acid as the only uranic 
acid present at the reducing terminals provides 
evidence for the existence of a heparan-sulfate- 
degrading endoglucuronidase. 
2. Materials and methods 
Fibroblast cultures from skin biopsies were 
established and maintained as described [4]. 
The intracellular [35S]heparan-sulfates from 
Hunter fibroblasts (mucopolysaccharidosis II, 
sulfoiduronide sulfatase deficiency) and Sanfilippo 
A fibroblasts (mucopolysaccharidosis III A, heparan- 
sulfate sulfamidase deficiency) were isolated as 
described [3]. The intracellular [35 Slheparan- 
sulfates derived from Scheie (mucopolysaccharidosis 
I S, a-L-iduronidase deficiency) and Sanfdippo B 
(mucopolysaccharidosis III B, cr-N-acetylglucosa- 
minidase deficiency) fibroblasts were those as 
described [3]. 
The intracellular [3sS]heparan-sulfates were 
reduced with [3H]NaBI& (NEN, Dreieichenhain) 
exactly as described [5]. After reduction the poly- 
saccharides were precipitated with 80% ethanol-l% 
potassium acetate (final concentration). The precipitate 
was subjected to chromatography on a 1.5 X 35 cm 
Sephadex G-50 column (Pharmacia, Uppsala) in 0.2 M 
pyridine-acetic acid, pH 5.5 in order to remove acid- 
resistant 3H-labelled low molecular material present in 
the commercially available [3H]NaBH4 preparations. 
The high molecular material was brought to dryness 
by evaporation. 
[‘H]Xylitol [6], [3H]galactitol [6], [3H]glycosa- 
minitol (see preparation of hexosamine fraction in ref. 
[7]) [8] and [3H]aldonic acids [5] were identified as 
already described. [3H]Idonic acid was prepared from 
L-iduronic acid isolated from the hydrolysate of 
dermatan sulfate by ion-exchange chromatography 
on Dowex 1 X 4 [lo]. The lactones of [3H]aldonic 
acids were prepared as described [9] and separated by 
chromatography on Selecta filter paper No. 2043 b 
(Schleicher Schiill, Dassel) in tert-amylalcohol-isopro- 
pyl alcohol-water (4: 1:2, v/v/v) [5]. 
Liquid scintillation counting was performed in a 
3390 Packard liquid scintillation counter, using 
Unisolve (Zinsser, Frankfurt) as the scintillation 
medium. 
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Results and discussion 
For analysis of the reducing-end groups the 
[35S]heparan-sulfate chains were treated with 
[3H]sodium borohydride, thus converting the 
reducing terminals into the corresponding sugar 
alcohols. 
The hydrolysates of the polysaccharides were 
analyzed for the 3H-derivatives of the sugars 
known to be present in heparan-sulfate, e.g. 
glucosamine, D-glucuronic acid, Liduronic acid, 
galactose and xylose. The only 3H-derivatives 
detectable were [3H]glucosaminitol and [3H]aldonic 
acids which were found in a ratio of 1.9: 1 for 
heparan-sulfate chains from Sanfilippo A fibroblasts 
and 6.8: 1 for heparan-sulfate chains from Hunter 
tibroblasts (table 1). These data are proof that 
glucosamine and uranic acid are reducing terminals 
and confirm the previous findings for intracellular 
heparan-sulfate stored in Sanfilippo B and Scheie 
fibroblasts, from which the existence of heparan- 
sulfate-degrading enzymes with the specificities of 
endoglucosaminidase(s) and endohexuronidase(s) were 
postulated [3]. 
D-Glucuronic acid and Liduronic acid are the uranic 
acids present in heparan-sulfate. The type of uranic 
acid present at the reducing terminals of the heparan- 
sulfates that accumulate in the different mucopoly- 
saccharidoses was identified after lactonization of the 
[‘Hlaldonic acid fraction. The only [3H]lactone 
detectable after separation by paper chromatography 
was that of L- [3H]gulonic acid (fig. l), the reduction 
product of D-glucuronic acid. The demonstration of 
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Fig. 1. identification of D-glucuronic acid as the reducing 
terminal of intracellular heparan-sulfate derived from Hunter 
fibroblasts. 1 A: Paper electrophoresis of the [‘Hlaldonic 
acid fraction. Electrophoresis was performed at 7.5 V/cm for 
45 min in 0.08 M pyridine-acetic acid, pH 5.3 [5]. 1 B: 
Paper chromatography of the lactonized (‘Hlaldonic acid 
frac,tion obtained after high-voltage lectrophoresis (fig.lA) 
in tert-amy alcohol/isopropyl alcohol/water (4:1:2, v/v/v) 
[ 51. Reference [ ‘HJuronosyl anhydro-mannitol (I), a mixture 
of [ ‘H]idonic acid and [‘H]gulonic acid (II), [ ‘H]gulonolac- 
tone (III) and [aH]idonolactone (IV). The lactonized [ ‘Hjal- 
donic acid fractions obtained from intracellular heparan- 
sulfates derived from Scheie, Sanfilippo A and Sanfilippo B 
fibroblasts, behaved indentically to that of Hunter fibroblasts. 
Table 1 
Distribution of 13Hlsugar derivatives at the reducingend of heparan-sulfates 
% of “H-Radioactivity 
Source of heparan-sulfate 13H]Xylitol 13HlGalactitol 13HlAldonic Acid 
Sanfilippo A 
Hunter 
n.d.a 
n.d. 
n.d. 65.4 34.6 
n.d. 87.8 12.2 
and.: not detectable. 
aHRadioactivity recovered as [3H]glycosaminitol and [3H]aldonic acid accounted for 67% (Sanfihppo A) 
and 78% (Hunter) of total ‘H-radioactivity and was taken as 100% for the calculations of this table. [aH]Glu- 
cosaminitol was corrected for a loss of 15% during hydrolysis [ 31. The residual “H-radioactivity was recovered 
in the neutral sugar fraction (prepared according to ref. [6]) and did not corn&ate with xylitol or with galac- 
titol. 
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D-glucuronic acid as the reducing terminal of intra- 
cellularly stored heparan-sulfate chains suggests that 
the heparan-sulfate-degrading endohexuronidase has 
the specificity of an endoglucuronidase. The existence 
of a heparan-sulfate-degrading endoglucuronidase is 
further-supported by experiments with a partially 
purified endoglycosidase preparation from human 
placenta which liberates oligosaccharides from 
heparan-sulfate chains with D-glucuronic acid at 
the reducing terminal (manuscript in preparation). 
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